Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Onur Baser, Krishna Tangirala, Wenhui Wei & Lin Xie. (2013) Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs. ClinicoEconomics and Outcomes Research 5, pages 497-505.
Read now
Read now
Stacy Griffin. (2013) Insulin treatment of type 2 diabetes: Considerations when converting from human insulin to insulin analogs. Annals of Medicine 45:2, pages 129-140.
Read now
Read now
Russell D. White. (2012) Patient empowerment and optimal glycemic control. Current Medical Research and Opinion 28:6, pages 979-989.
Read now
Read now
Articles from other publishers (18)
Di SunXu ZhangXiu-xin Hou. (2018) Effects of Insulin Treatment with Glargine or Premixed Insulin Lispro Programs in Type 2 Diabetes Mellitus Patients: A Meta-analysis of Randomized Clinical Trials. Diabetes Technology & Therapeutics 20:9, pages 622-627.
Crossref
Crossref
Pan-wei Mu, De-zhao Liu, Ying Lin, Dong Liu, Fan Zhang, Yong-jun Zhang, Shuo Lin, Lin-qin Wang, Man-man Wang, Jiong Shu, Long-yi Zeng & Yan-ming Chen. (2018) The Postprandial-to-Fasting Serum C-Peptide Ratio is a Predictor of Response to Basal Insulin-Supported Oral Antidiabetic Drug(s) Therapy: A Retrospective Analysis. Diabetes Therapy 9:3, pages 963-971.
Crossref
Crossref
Yue Gao, Ke Wang, Yun Chen, Li Shen, Jianing Hou, Jianwei Xuan & Bao Liu. (2018) A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis. Diabetes Therapy 9:2, pages 673-682.
Crossref
Crossref
A.J. Scheen, H. Schmitt, H.H. Jiang & T. Ivanyi. (2017) Factors associated with reaching or not reaching target HbA1c after initiation of basal or premixed insulin in patients with type 2 diabetes. Diabetes & Metabolism 43:1, pages 69-78.
Crossref
Crossref
Przemyslaw Rys, Piotr Wojciechowski, Agnieszka Rogoz-Sitek, Grzegorz Niesyczyński, Joanna Lis, Albert Syta & Maciej T. Malecki. (2015) Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus. Acta Diabetologica 52:4, pages 649-662.
Crossref
Crossref
Philip D. Home, Marie-Paule Dain, Nick Freemantle, Ryuzo Kawamori, Martin Pfohl, Sandrine Brette, Valérie Pilorget, Werner A. Scherbaum, Giacomo Vespasiani, Maya Vincent & Beverley Balkau. (2015) Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents. Diabetes Research and Clinical Practice 108:2, pages 350-359.
Crossref
Crossref
Asrul Akmal Shafie, Vishal Gupta, Ranya Baabbad, Eva Hammerby & Philip Home. (2014) An analysis of the short- and long-term cost-effectiveness of starting biphasic insulin aspart 30 in insulin-naïve people with poorly controlled type 2 diabetes. Diabetes Research and Clinical Practice 106:2, pages 319-327.
Crossref
Crossref
Esther M. M. van de Glind, Hanneke F. M. Rhodius-Meester, Johannes B. Reitsma, Lotty Hooft & Barbara C. van Munster. (2014) Reviews of Individual Patient Data (IPD) Are Useful for Geriatrics: An Overview of Available IPD Reviews. Journal of the American Geriatrics Society 62:6, pages 1133-1138.
Crossref
Crossref
A. J. Garber. (2013) Treat‐to‐target trials: uses, interpretation and review of concepts. Diabetes, Obesity and Metabolism 16:3, pages 193-205.
Crossref
Crossref
Siddharth ShahWenying YangMohammad Imtiaz HasanRachid MalekOle Molskov BechPhilip Home. (2013)
Biphasic Insulin Aspart 30 in Insulin-Naive People with Type 2 Diabetes in Non-western Nations: Results from a Regional Comparative Multinational Observational Study (A
1
chieve)
. Diabetes Technology & Therapeutics 15:11, pages 954-963.
Crossref
Crossref
Luigi F. Meneghini. (2013) Intensifying Insulin Therapy: What Options Are Available to Patients with Type 2 Diabetes?. The American Journal of Medicine 126:9, pages S28-S37.
Crossref
Crossref
Rachid Malek, Zakia Arbouche, Malika Bachaoui, Sakina Zinai, Amine Dahaoui, Souror Senoussaoui & Abdellah Salah-Mansour. (2013) Criteria influencing the choice of starting insulin regimen in patients with type 2 diabetes in routine clinical practice: baseline data from the Algerian cohort of the A1chieve study. Diabetes Research and Clinical Practice 101, pages S45-S49.
Crossref
Crossref
Geralyn R. Spollett. (2012) Insulin initiation in type 2 diabetes: What are the treatment regimen options and how can we best help patients feel empowered?. Journal of the American Academy of Nurse Practitioners 24, pages 249-259.
Crossref
Crossref
Asuka Ota & Yibin Wang. (2012) Cdc37/Hsp90 Protein-mediated Regulation of IRE1α Protein Activity in Endoplasmic Reticulum Stress Response and Insulin Synthesis in INS-1 Cells. Journal of Biological Chemistry 287:9, pages 6266-6274.
Crossref
Crossref
Andrew J. Krentz & Alan J. Sinclair. (2011) Choice of Long-Acting Insulin Therapy for Type 2 Diabetes. Drugs & Aging 28:12, pages 935-941.
Crossref
Crossref
Philip A. Levin, Quanwu Zhang, James H. Mersey, Francis Y. Lee, Lee A. Bromberger, Madhu Bhushan & Rajat Bhushan. (2011) Glycemic Control With Insulin Glargine Plus Insulin Glulisine Versus Premixed Insulin Analogues in Real-World Practices: A Cost-Effectiveness Study With a Randomized Pragmatic Trial Design. Clinical Therapeutics 33:7, pages 841-850.
Crossref
Crossref
Frank Lavernia. (2011) What Options Are Available When Considering Starting Insulin: Premix or Basal?. Diabetes Technology & Therapeutics 13:S1, pages S-85-S-92.
Crossref
Crossref
Yasuhiro Hosoi, Ken-Ichi Ohtani, Hiroyuki Shimizu, Kouji Kashima, Noriyuki Sato, Hitoshi Akiyama & Masatomo Mori. (2011) Attainment of glycaemic goals by step-up therapy with biphasic insulin aspart-70/30 in Japanese type 2 diabetic patients. Endocrine Journal 58:2, pages 131-135.
Crossref
Crossref